T1	Participants 371 511	512 patients (conformally treated to 68 Gy [n = 284] and 78 Gy [n = 228]) with complete follow-up at 3 years after radiotherapy were studied
T2	Participants 46 139	rectal normal tissue complication probability modeling after radiotherapy for prostate cancer
T3	Participants 513 598	Scored end points were rectal bleeding, high stool frequency, and fecal incontinence.
